Cardiovascular Mortality

Researchers identified significant U-shaped associations between sleep duration and cardiovascular mortality, 10-year atherosclerotic CVD risk and C-reactive protein, a marker of inflammation.

Study participants who were randomly assigned to receive cocoa flavanol supplementation had a 27% lower risk for cardiovascular death than those assigned to placebo, according to data published in The American Journal of Clinical Nutrition.

A medical team in Maryland successfully transplanted a genetically modified pig heart into a human for the first time in history.

Adults with heart failure with reduced ejection fraction derived similar benefits with empagliflozin regardless of other disease-modifying heart failure therapies prescribed at baseline, post hoc analysis of the EMPEROR-Reduced trial show.

Data that indicated better outcomes among some patients with cardiac arrest who had epinephrine administered fewer than 5 minutes after their first defibrillation was the top story in cardiology last week.

The “strong associations” of urine-to-plasma ratios with cardiovascular mortality implies a connection between renal clearance of uremic solutes and CVD pathogenesis, according to a speaker from ASN Kidney Week.

Patients on maintenance hemodialysis who engaged in occasional or frequent physical activity were less likely to die from cardiovascular causes compared with those who reported being physically inactive.

Nonalcoholic fatty liver disease correlated with an increased long-term risk for cardiovascular events and may be an independent risk factor for CVD morbidity and mortality, according to research.

Regarding cardiovascular mortality, results published in the Scandinavian Journal of Gastroenterology demonstrated a negative interaction between fatty liver disease and hypertension in nondiabetic men.

Obstructive sleep apnea is a significant risk factor for all-cause sudden death and cardiovascular mortality, according to findings published in BMJ Open Respiratory Research.